Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
暂无分享,去创建一个
David M. Thomas | Jason Li | Jason Ellul | Alexander Dobrovic | Stephen B Fox | Stephen Q Wong | Andrew Fellowes | S. Fox | H. Do | A. Dobrovic | G. McArthur | R. Vedururu | Jason Li | K. Doig | J. Parisot | S. Wong | J. Ellul | A. Fellowes | Ken Doig | A. Tan | J. Pang | Anthony Bell | Grant MacArthur | Hongdo Do | Anthony H. Bell | Ravikiran Vedururu | John P Parisot | David M Thomas | Angela Y-C Tan | Jia-Min B Pang | Anthony Bell | Grant A MacArthur | D. Thomas | S. Fox
[1] H. Lehrach,et al. Genome-Wide Massively Parallel Sequencing of Formaldehyde Fixed-Paraffin Embedded (FFPE) Tumor Tissues for Copy-Number- and Mutation-Analysis , 2009, PloS one.
[2] Bauke Ylstra,et al. EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study. , 2013, Lung cancer.
[3] D. Kell. BMC Medical Genomics , 2008 .
[4] Jesse J. Salk,et al. Detection of ultra-rare mutations by next-generation sequencing , 2012, Proceedings of the National Academy of Sciences.
[5] Richard B. Schwab,et al. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens , 2012, Nucleic acids research.
[6] A. Oza,et al. A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors , 2013, Investigational New Drugs.
[7] A. von Deimling,et al. Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma. , 2012, Endocrine-related cancer.
[8] T. Lindahl. Instability and decay of the primary structure of DNA , 1993, Nature.
[9] Alexander Dobrovic,et al. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase , 2012, Oncotarget.
[10] Keith L. Ligon,et al. Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples , 2009, PloS one.
[11] K. Becker,et al. Use of formalin-fixed and paraffin-embedded tissues for diagnosis and therapy in routine clinical settings. , 2011, Methods in molecular biology.
[12] L. Garraway,et al. Clinical implications of the cancer genome. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] James Denvir,et al. DNA damage reduces Taq DNA polymerase fidelity and PCR amplification efficiency. , 2007, Biochemical and biophysical research communications.
[14] A. V. Chernikov,et al. Heat-induced formation of reactive oxygen species and 8-oxoguanine, a biomarker of damage to DNA. , 2002, Nucleic acids research.
[15] Rosette Lidereau,et al. PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups , 2012, Breast Cancer Research.
[16] Nikhil Wagle,et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.
[17] Razelle Kurzrock,et al. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] F. Kelleher,et al. Targeting NRAS in Melanoma , 2012, Cancer journal.
[19] C. Tzen,et al. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma , 2011, Pigment cell & melanoma research.
[20] John D Pfeifer,et al. Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. , 2013, The Journal of molecular diagnostics : JMD.
[21] Michael Worobey,et al. The Isolation of Nucleic Acids from Fixed, Paraffin-Embedded Tissues–Which Methods Are Useful When? , 2007, PloS one.
[22] R. Tothill,et al. BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage , 2013, Clinical Cancer Research.
[23] Jason Li,et al. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. , 2013, Clinical chemistry.
[24] H. Do,et al. Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors , 2013, BMC Medical Genomics.
[25] A. von Haeseler,et al. DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA. , 2001, Nucleic acids research.
[26] Krister Wennerberg,et al. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. , 2013, Cancer discovery.
[27] R. Tothill,et al. Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours , 2013, Scientific Reports.
[28] C. Berking,et al. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. , 2013, The Lancet. Oncology.
[29] G. Pfeifer,et al. Mutations induced by ultraviolet light. , 2005, Mutation research.
[30] Adam C. Marko,et al. Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies , 2013, Genome Medicine.
[31] Ralf Herwig,et al. Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity , 2011, BMC Medical Genomics.